Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 726

1.

Ginsenoside Re ameliorates inflammation by inhibiting the binding of lipopolysaccharide to TLR4 on macrophages.

Lee IA, Hyam SR, Jang SE, Han MJ, Kim DH.

J Agric Food Chem. 2012 Sep 26;60(38):9595-602. Epub 2012 Sep 12.

PMID:
22849695
2.

Ursolic acid isolated from the seed of Cornus officinalis ameliorates colitis in mice by inhibiting the binding of lipopolysaccharide to Toll-like receptor 4 on macrophages.

Jang SE, Jeong JJ, Hyam SR, Han MJ, Kim DH.

J Agric Food Chem. 2014 Oct 8;62(40):9711-21. doi: 10.1021/jf501487v. Epub 2014 Sep 23.

PMID:
25213465
3.

Anti-inflammatory effects of ginsenoside Rg1 and its metabolites ginsenoside Rh1 and 20(S)-protopanaxatriol in mice with TNBS-induced colitis.

Lee SY, Jeong JJ, Eun SH, Kim DH.

Eur J Pharmacol. 2015 Sep 5;762:333-43. doi: 10.1016/j.ejphar.2015.06.011. Epub 2015 Jun 6.

PMID:
26054809
4.

Soyasaponin Ab ameliorates colitis by inhibiting the binding of lipopolysaccharide (LPS) to Toll-like receptor (TLR)4 on macrophages.

Lee IA, Park YJ, Joh EH, Kim DH.

J Agric Food Chem. 2011 Dec 28;59(24):13165-72. doi: 10.1021/jf2033818. Epub 2011 Nov 18.

PMID:
22060784
5.

Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation--the key step of inflammation.

Joh EH, Lee IA, Jung IH, Kim DH.

Biochem Pharmacol. 2011 Aug 1;82(3):278-86. doi: 10.1016/j.bcp.2011.05.003. Epub 2011 May 12.

PMID:
21600888
6.

Arctigenin ameliorates inflammation in vitro and in vivo by inhibiting the PI3K/AKT pathway and polarizing M1 macrophages to M2-like macrophages.

Hyam SR, Lee IA, Gu W, Kim KA, Jeong JJ, Jang SE, Han MJ, Kim DH.

Eur J Pharmacol. 2013 May 15;708(1-3):21-9. doi: 10.1016/j.ejphar.2013.01.014. Epub 2013 Jan 31.

PMID:
23375938
7.

Anti-inflammatory effects of vina-ginsenoside R2 and majonoside R2 isolated from Panax vietnamensis and their metabolites in lipopolysaccharide-stimulated macrophages.

Jeong JJ, Van Le TH, Lee SY, Eun SH, Nguyen MD, Park JH, Kim DH.

Int Immunopharmacol. 2015 Sep;28(1):700-6. doi: 10.1016/j.intimp.2015.07.025. Epub 2015 Aug 5.

PMID:
26256699
8.

Echinocystic acid, a metabolite of lancemaside A, inhibits TNBS-induced colitis in mice.

Hyam SR, Jang SE, Jeong JJ, Joh EH, Han MJ, Kim DH.

Int Immunopharmacol. 2013 Feb;15(2):433-41. doi: 10.1016/j.intimp.2012.12.017. Epub 2013 Jan 23.

PMID:
23352442
9.

Kalopanaxsaponin B inhibits LPS-induced inflammation by inhibiting IRAK1 Kinase.

Joh EH, Jeong JJ, Kim DH.

Cell Immunol. 2012 Sep;279(1):103-8. doi: 10.1016/j.cellimm.2012.10.001. Epub 2012 Oct 12.

PMID:
23117333
10.

Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK-1 activation in the NF-κB and MAPK pathways.

Joh EH, Kim DH.

Br J Pharmacol. 2011 Apr;162(8):1731-42. doi: 10.1111/j.1476-5381.2010.01195.x.

11.

Mangiferin ameliorates colitis by inhibiting IRAK1 phosphorylation in NF-κB and MAPK pathways.

Jeong JJ, Jang SE, Hyam SR, Han MJ, Kim DH.

Eur J Pharmacol. 2014 Oct 5;740:652-61. doi: 10.1016/j.ejphar.2014.06.013. Epub 2014 Jun 24.

PMID:
24972244
12.

Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.

Xia MZ, Liang YL, Wang H, Chen X, Huang YY, Zhang ZH, Chen YH, Zhang C, Zhao M, Xu DX, Song LH.

J Pineal Res. 2012 Nov;53(4):325-34. doi: 10.1111/j.1600-079X.2012.01002.x. Epub 2012 Apr 27.

PMID:
22537289
13.

Echinocystic acid ameliorates lung inflammation in mice and alveolar macrophages by inhibiting the binding of LPS to TLR4 in NF-κB and MAPK pathways.

Joh EH, Gu W, Kim DH.

Biochem Pharmacol. 2012 Aug 1;84(3):331-40. doi: 10.1016/j.bcp.2012.04.020. Epub 2012 May 4.

PMID:
22564908
14.

Penta-O-galloyl-β-D-glucose ameliorates inflammation by inhibiting MyD88/NF-κB and MyD88/MAPK signalling pathways.

Jang SE, Hyam SR, Jeong JJ, Han MJ, Kim DH.

Br J Pharmacol. 2013 Nov;170(5):1078-91. doi: 10.1111/bph.12333.

15.

Lactobacillus brevis G-101 ameliorates colitis in mice by inhibiting NF-κB, MAPK and AKT pathways and by polarizing M1 macrophages to M2-like macrophages.

Jang SE, Hyam SR, Han MJ, Kim SY, Lee BG, Kim DH.

J Appl Microbiol. 2013 Sep;115(3):888-96. doi: 10.1111/jam.12273. Epub 2013 Jul 1.

16.

Ginsenoside Rg5 ameliorates lung inflammation in mice by inhibiting the binding of LPS to toll-like receptor-4 on macrophages.

Kim TW, Joh EH, Kim B, Kim DH.

Int Immunopharmacol. 2012 Jan;12(1):110-6. doi: 10.1016/j.intimp.2011.10.023. Epub 2011 Nov 19.

PMID:
22107725
17.

β-Sitosterol attenuates high-fat diet-induced intestinal inflammation in mice by inhibiting the binding of lipopolysaccharide to toll-like receptor 4 in the NF-κB pathway.

Kim KA, Lee IA, Gu W, Hyam SR, Kim DH.

Mol Nutr Food Res. 2014 May;58(5):963-72. doi: 10.1002/mnfr.201300433. Epub 2014 Jan 9.

PMID:
24402767
18.

Lancemaside A ameliorates colitis by inhibiting NF-kappaB activation in TNBS-induced colitis mice.

Joh EH, Lee IA, Han SJ, Chae S, Kim DH.

Int J Colorectal Dis. 2010 May;25(5):545-51. doi: 10.1007/s00384-009-0858-0. Epub 2009 Dec 3.

PMID:
19956958
19.

Kakkalide and its metabolite irisolidone ameliorate carrageenan-induced inflammation in mice by inhibiting NF-κB pathway.

Min SW, Park YJ, Kim DH.

Inflammation. 2011 Oct;34(5):344-51. doi: 10.1007/s10753-010-9240-1.

PMID:
20686830
20.

Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-κB activation.

Lee IA, Hyun YJ, Kim DH.

Eur J Pharmacol. 2010 Dec 1;648(1-3):162-70. doi: 10.1016/j.ejphar.2010.08.046. Epub 2010 Sep 7.

PMID:
20828550

Supplemental Content

Support Center